Ikarovec has presented preclinical evidence for IKAR-001, a dual-pathway gene therapy designed to combine complement ...

Researchers also reported results from a separate trial of a gene therapy the company is developing for PKP2-related arrhythmogenic cardiomyopathy.

NEW YORK, NY, UNITED STATES, March 31, 2026 /EINPresswire.com/ -- Queens-based creator Larry Ng and Northwell Health – ...

The notorious disease known as sleeping sickness can lurk inside a host for months or even years before serious symptoms ...

Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 March 27, 2026 8:30 ...

The FDA granted accelerated approval to Kresladi for the treatment of pediatric patients with severe LAD-I due to biallelic variants in ITGB2 without an available HLA-matched sibling donor for ...

Nadofaragene firadenovec-vncg is the only FDA-approved nonreplicating intravesical gene therapy for high-risk ...

About Addgene Addgene is a purpose-driven organization committed to accelerating discovery and innovation by helping scientists conduct experiments with greater ease, speed, and r ...

Researchers have engineered Arabidopsis plants that emit visible light when their immune defenses switch on, creating a ...

Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical Administration Bureau of Macao Special ...

The key for optimizing cell-line development for antibody derivatives might just be to prioritize early assessment of product ...

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a ...